Hims & Hers Health Surges, Live Nation Entertainment Rises, Brown-Forman Falls as Bernstein Downgrades on Costly Whiskey

Mar 9, 2026

Nora Melinda, Bloomberg studio contributor who breaks down market movers. She discusses Hims & Hers leaping after a Novo Nordisk partnership. She walks through Live Nation’s DOJ settlement and its market implications. She covers Bernstein’s downgrade of Brown-Forman tied to costly barreled whiskey and margin worries.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Novo Nordisk Deal Sparks Massive Hims Rally

Hims & Hers stock jumped after Novo Nordisk agreed to sell obesity drugs on the Hims platform.
The deal resolves prior public dispute over copycat drugs and lifted HIMS shares up to 49% while NVO rose about 2.6%.

INSIGHT

DOJ Settlement Boosts Live Nation Shares

Live Nation shares rose after the company reached a settlement with the DOJ in its antitrust case.
Analysts view the deal as positive and not requiring Ticketmaster's sale, with a file agreement possibly announced days after trial intensified on March 2nd.

INSIGHT

Whiskey Inventory Concerns Trigger Brown-Forman Downgrade

Brown-Forman fell after Bernstein downgraded the stock to market perform citing margin pressure from costly barreled whiskey.
Analyst Nadine Sarwat emphasized the change targets margin risk from larger, longer-aged whiskey stocks, not structural alcohol demand shifts.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

On this episode of Stock Movers:

- Him & Hers (HIMS) shares surge after Novo Nordisk was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform. Novo and Hims plan to announce a new partnership as soon as Monday, according to a person familiar with the matter, who spoke on the condition of anonymity.

- Live Nation Entertainment (LYV) shares rise. Live Nation Entertainment Inc. and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities, according to the Justice Department. The agreement was announced with no details provided, but it would reportedly open parts of Live Nation's ticketing arm to third-party sellers and make it easier for other promoters to put on shows at amphitheaters that Live Nation controls.

- Brown-Forman (BF/B) shares fall after Bernstein analyst Nadine Sarwat cut her recommendation on the alcohol beverage company to market perform from outperform. “This rating change isn’t about the structural vs. cyclical debate in US alcohol or the risk of price wars (from the US ‘whiskey glut’ or competitors) — our views on this remain unchanged,” Sarwat writes.

On this episode of Stock Movers:

See omnystudio.com/listener for privacy information.